vidarabine phosphate has been researched along with entinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czarnik, AC; Dai, Y; Grant, S; Kramer, LB; Maggio, SC; Paik, DS; Payne, SG; Rahmani, M; Rosato, RR; Spiegel, S | 1 |
1 other study(ies) available for vidarabine phosphate and entinostat
Article | Year |
---|---|
The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Caspases; Cell Cycle; Cell Cycle Proteins; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Humans; Jurkat Cells; Leukemia; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Mitochondria; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyridines; Reactive Oxygen Species; S Phase; Tumor Necrosis Factor-alpha; U937 Cells; Vidarabine Phosphate | 2004 |